Get the app!
Back to Trades
Total Value
$2.0K
Net $2.0K bought
Filing Date
Jun 22, 2026
2 transactions
Purchases
$2.0K
2 transactions

Trade Summary

On Jun 17, 2026 through Jun 18, 2026, Altman Peter, President and CEO, Director, purchased $2.0K of BioCardia, Inc. (BCDA) across 2 transactions. The filing covers Common Stock and reflects net buying of $2.0K. Reported prices ranged from $0.85 to $0.96. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Company Name
BioCardia, Inc.
Ticker Symbol
BCDA
CIK
0000925741

Insider Information

Role
President and CEO, Director
Location
SUNNYVALE, CA

Filing Details

Filing Date
Jun 22, 2026
Transaction Date
Jun 17, 2026
Accession Number
0001437749-26-021216
Form Type
4
Net Trading Amount
$2.0K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Jun 17, 2026Common Stock1,500$0.85Purchase$1.3K
Jun 18, 2026Common Stock800$0.96Purchase$768

Want live alerts when Altman Peter trades again?

Download Insider Trades to track BCDA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)This transaction was executed in multiple trades ranging from $0.84 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
  2. (F2)This transaction was executed in multiple trades ranging from $0.98 to $0.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.